论文部分内容阅读
据《国际药品市场信息》（ＩＭＳ）保健版称，到下个世纪，各种新药的上市将成为美国医药行业销售额增长的主要促进剂。 １９９９年至２００２年间将有４５种具明显销售潜力的新药上市，Ｓｅａｒｌｅ公司的ｃｅｌｅｃｏｘｉｂ（Ｃｅｌｅｂｒｅｘ）以及Ｍｅｒｃｋ＆ Ｃｏ公司的
According to the IMS Health Edition, the listing of new drugs by the next century will be a major boost for the U.S. pharmaceutical industry’s sales growth. Between 2011 and 2002, 45 new drugs with significant sales potential will be available, Selecle’s celecoxib (Celebrex) and Merck & Co.’s